These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 25059654)
21. Gleditsioside B, a triterpene saponin isolated from the anomalous fruits of Gleditsia sinensis Lam., abrogates bFGF-induced endothelial cell migration through preventing the activation of MMP-2 and FAK via inhibiting ERK and PI3K/AKT signaling pathways. Tong B; Lu D; Wei Z; Wang T; Xia Y; Dai Y Vascul Pharmacol; 2013 Jan; 58(1-2):118-26. PubMed ID: 23026290 [TBL] [Abstract][Full Text] [Related]
22. Ferulic Acid Exerts Anti-Angiogenic and Anti-Tumor Activity by Targeting Fibroblast Growth Factor Receptor 1-Mediated Angiogenesis. Yang GW; Jiang JS; Lu WQ Int J Mol Sci; 2015 Oct; 16(10):24011-31. PubMed ID: 26473837 [TBL] [Abstract][Full Text] [Related]
23. Antitumor effects and chemical compositions of Eupolyphaga sinensis Walker ethanol extract. Ge GF; Yu CH; Yu B; Shen ZH; Zhang DL; Wu QF J Ethnopharmacol; 2012 May; 141(1):178-82. PubMed ID: 22366674 [TBL] [Abstract][Full Text] [Related]
24. Orally Administered Mucolytic Drug l-Carbocisteine Inhibits Angiogenesis and Tumor Growth in Mice. Shinya T; Yokota T; Nakayama S; Oki S; Mutoh J; Takahashi S; Sato K J Pharmacol Exp Ther; 2015 Sep; 354(3):269-78. PubMed ID: 26126534 [TBL] [Abstract][Full Text] [Related]
25. Jiedu Xiaozheng Yin, a Chinese herbal formula, inhibits tumor angiogenesis via downregulation of VEGF-A and VEGFR-2 expression in vivo and in vitro. Cao Z; Lin W; Huang Z; Chen X; Zhao J; Zheng L; Ye H; Liu Z; Liao L; Du J Oncol Rep; 2013 Mar; 29(3):1080-6. PubMed ID: 23254951 [TBL] [Abstract][Full Text] [Related]
26. Domain I-IV of β2-glycoprotein I inhibits advanced glycation end product-induced angiogenesis by down-regulating vascular endothelial growth factor 2 signaling. Wang QQ; Zhou SJ; Meng ZX; Wang J; Chen R; Lv L; Li CJ; Yu DM; Yu P Mol Med Rep; 2015 Mar; 11(3):2167-72. PubMed ID: 25405610 [TBL] [Abstract][Full Text] [Related]
27. KRC-408, a novel c-Met inhibitor, suppresses cell proliferation and angiogenesis of gastric cancer. Hong SW; Jung KH; Park BH; Zheng HM; Lee HS; Choi MJ; Yun JI; Kang NS; Lee J; Hong SS Cancer Lett; 2013 May; 332(1):74-82. PubMed ID: 23348694 [TBL] [Abstract][Full Text] [Related]
28. Anti-angiogenic activity of carebastine: a plausible mechanism affecting airway remodelling. De Luisi A; Mangialardi G; Ria R; Acuto G; Ribatti D; Vacca A Eur Respir J; 2009 Oct; 34(4):958-66. PubMed ID: 19357149 [TBL] [Abstract][Full Text] [Related]
29. Rhein inhibits angiogenesis and the viability of hormone-dependent and -independent cancer cells under normoxic or hypoxic conditions in vitro. Fernand VE; Losso JN; Truax RE; Villar EE; Bwambok DK; Fakayode SO; Lowry M; Warner IM Chem Biol Interact; 2011 Jul; 192(3):220-32. PubMed ID: 21457705 [TBL] [Abstract][Full Text] [Related]
30. Decursin and decursinol angelate inhibit VEGF-induced angiogenesis via suppression of the VEGFR-2-signaling pathway. Jung MH; Lee SH; Ahn EM; Lee YM Carcinogenesis; 2009 Apr; 30(4):655-61. PubMed ID: 19228635 [TBL] [Abstract][Full Text] [Related]
31. Norcantharidin inhibits tumor angiogenesis via blocking VEGFR2/MEK/ERK signaling pathways. Zhang L; Ji Q; Liu X; Chen X; Chen Z; Qiu Y; Sun J; Cai J; Zhu H; Li Q Cancer Sci; 2013 May; 104(5):604-10. PubMed ID: 23363445 [TBL] [Abstract][Full Text] [Related]
32. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells. Chen MC; Lee CF; Huang WH; Chou TC Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116 [TBL] [Abstract][Full Text] [Related]
33. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models. Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925 [TBL] [Abstract][Full Text] [Related]
34. Cat's whiskers tea (Orthosiphon stamineus) extract inhibits growth of colon tumor in nude mice and angiogenesis in endothelial cells via suppressing VEGFR phosphorylation. Ahamed MB; Aisha AF; Nassar ZD; Siddiqui JM; Ismail Z; Omari SM; Parish CR; Majid AM Nutr Cancer; 2012; 64(1):89-99. PubMed ID: 22136553 [TBL] [Abstract][Full Text] [Related]
35. Antiangiogenic properties of cafestol, a coffee diterpene, in human umbilical vein endothelial cells. Wang S; Yoon YC; Sung MJ; Hur HJ; Park JH Biochem Biophys Res Commun; 2012 May; 421(3):567-71. PubMed ID: 22525673 [TBL] [Abstract][Full Text] [Related]
36. Penduliflaworosin, a Diterpenoid from Croton crassifolius, Exerts Anti-Angiogenic Effect via VEGF Receptor-2 Signaling Pathway. Liang Y; Zhang Y; Wang G; Li Y; Huang W Molecules; 2017 Jan; 22(1):. PubMed ID: 28098802 [TBL] [Abstract][Full Text] [Related]
37. Recombinant adeno-associated virus-delivered anginex inhibits angiogenesis and growth of HUVECs by regulating the Akt, JNK and NF-κB signaling pathways. Ma K; Wang C; Geng Q; Fan Y; Ning J; Yang H; Dong X; Dong D; Guo Y; Wei X; Li E; Wu Y Oncol Rep; 2016 Jun; 35(6):3505-13. PubMed ID: 27035232 [TBL] [Abstract][Full Text] [Related]
38. Inhibition of vascular endothelial growth factor-induced angiogenesis by scopoletin through interrupting the autophosphorylation of VEGF receptor 2 and its downstream signaling pathways. Pan R; Dai Y; Gao XH; Lu D; Xia YF Vascul Pharmacol; 2011; 54(1-2):18-28. PubMed ID: 21078410 [TBL] [Abstract][Full Text] [Related]
39. The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis. Heckman CA; Holopainen T; Wirzenius M; Keskitalo S; Jeltsch M; Ylä-Herttuala S; Wedge SR; Jürgensmeier JM; Alitalo K Cancer Res; 2008 Jun; 68(12):4754-62. PubMed ID: 18559522 [TBL] [Abstract][Full Text] [Related]
40. An-te-xiao capsule inhibits tumor growth in non-small cell lung cancer by targeting angiogenesis. Han L; Wang JN; Cao XQ; Sun CX; Du X Biomed Pharmacother; 2018 Dec; 108():941-951. PubMed ID: 30372906 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]